Skip to search formSkip to main contentSkip to account menu

DM 232

Known as: DM-232, unifiram 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PiperazinesPyrroles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings
  • F. Gualtieri
  • Journal of Enzyme Inhibition and Medicinal…
  • 2016
  • Corpus ID: 207528957
Abstract This paper is a review of the work of my former academic group of research in the past 15 years, in the field of… 
2008
2008
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
Review
2006
Review
2006
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.
DM232 (unifiram) and DM235 (sunifiram) are potent cognition-enhancers, which are four order of magnitude more potent than… 
2005
2005
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent.
The enantiomers of the potent cognition-enhancer DM232 ((1), unifiram) and of its isopropylsulfonyl analog (2), which is endowed… 
2004
2004
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.
2003
2003
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram)
DM 232 and DM 235 are novel antiamnesic compounds structurally related to ampakines. The involvement of AMPA receptors in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)